Insight Molecular Diagnostics (IMDX) Gross Profit (2020 - 2025)
Historic Gross Profit for Insight Molecular Diagnostics (IMDX) over the last 6 years, with Q3 2025 value amounting to $139000.0.
- Insight Molecular Diagnostics' Gross Profit rose 17800.0% to $139000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $2.4 million, marking a year-over-year increase of 850357.14%. This contributed to the annual value of $740000.0 for FY2024, which is 7917.68% up from last year.
- According to the latest figures from Q3 2025, Insight Molecular Diagnostics' Gross Profit is $139000.0, which was up 17800.0% from $350000.0 recorded in Q2 2025.
- In the past 5 years, Insight Molecular Diagnostics' Gross Profit registered a high of $2.6 million during Q4 2021, and its lowest value of -$866000.0 during Q3 2021.
- In the last 5 years, Insight Molecular Diagnostics' Gross Profit had a median value of $50000.0 in 2024 and averaged $188894.7.
- Per our database at Business Quant, Insight Molecular Diagnostics' Gross Profit crashed by 178260.87% in 2021 and then surged by 284444.44% in 2025.
- Over the past 5 years, Insight Molecular Diagnostics' Gross Profit (Quarter) stood at $2.6 million in 2021, then crashed by 101.04% to -$27000.0 in 2022, then crashed by 333.33% to -$117000.0 in 2023, then soared by 608.55% to $595000.0 in 2024, then plummeted by 76.64% to $139000.0 in 2025.
- Its Gross Profit stands at $139000.0 for Q3 2025, versus $350000.0 for Q2 2025 and $1.3 million for Q1 2025.